SCHEMBL743719

SCHEMBL743719

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN)cc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.55
BCR P11274 2/20 0.55
AURKA O14965 7/20 0.51
TRPV1 Q8NER1 1/20 0.39
FLT3 P36888 2/20 0.37
HDAC6 Q9UBN7 1/20 0.37
IMPDH2 P12268 1/20 0.37
PLG P00747 2/20 0.37
KLK1 P06870 2/20 0.37
KLK6 Q92876 2/20 0.37
FGFR1 P11362 1/20 0.37
FGFR2 P21802 1/20 0.37
FGFR3 P22607 1/20 0.37
HDAC1 Q13547 1/20 0.37
KLKB1 P03952 1/20 0.37
KCNK9 Q9NPC2 1/20 0.36
KIT P10721 1/20 0.36
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740292 0.91 AURKA (0.55) ABL1BCRAURKAHDAC6IMPDH2
SCHEMBL739669 0.89 ABL1 (0.53) ABL1BCRAURKAFLT3HDAC6
SCHEMBL738866 0.88 AURKA (0.53) ABL1BCRAURKAFLT3HDAC6
SCHEMBL741311 0.88 AURKA (0.53) ABL1BCRAURKAFLT3HDAC6
SCHEMBL741133 0.88 ABL1 (0.54) ABL1BCRAURKAFLT3HDAC6
SCHEMBL743001 0.87 ABL1 (0.51) ABL1BCRAURKAFLT3HDAC6
SCHEMBL740809 0.87 AURKA (0.52) ABL1BCRAURKAHDAC6IMPDH2
SCHEMBL742638 0.86 ABL1 (0.74) ABL1BCRAURKAFLT3FGFR1
SCHEMBL739415 0.86 ABL1 (0.53) ABL1BCRAURKAFLT3HDAC1
SCHEMBL740623 0.86 ABL1 (0.72) ABL1BCRAURKAFLT3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed